Rapid Microfluidic Biosensor for Point-of-Care Determination of Rheumatoid Arthritis via Anti-Cyclic Citrullinated Peptide Antibody Detection [PDF]
BiosensorsRheumatoid arthritis (RA) is a chronic autoimmune disorder that causes extensive damage to multiple organs and tissues and has no known cure. This study introduces a microfluidic detection platform that combines a microfluidic reaction chip with a micro ...
Wei-Yu Tai +3 more
doaj +3 more sources
A retrospective analysis of the relationship between anti-cyclic citrullinated peptide antibody and interstitial lung disease in systemic sclerosis [PDF]
Scientific Reports, 2022 Anti-cyclic citrullinated peptide antibody testing is used to diagnose rheumatoid arthritis and associated with interstitial lung disease in RA. Herein, we investigate the relationship between anti-CCP antibody and ILD in SSc.
Jang Woo Ha +8 more
doaj +3 more sources
Anti-Cyclic Citrullinated Peptide Antibody-Positive Meningoencephalitis in the Preclinical Period of Rheumatoid Arthritis [PDF]
Case Reports in Neurology, 2016 Rheumatoid meningoencephalitis (RM) is a rare complication of rheumatoid arthritis (RA). This report describes a 63-year-old man with complaints of high-grade fever, headache, and vomiting for several days before admission.
Tomoya Shibahara +8 more
doaj +3 more sources
Anti-cyclic citrullinated peptide antibody and pain sensitisation in patients with rheumatoid arthritis: a cross-sectional analysis. [PDF]
Ann Rheum Dis, 2023 http://deepblue.lib.umich.edu/bitstream/2027.42/198095/2/Anti-cyclic citrullinated peptide antibody and pain sensitisation in patients with rheumatoid arthritis a cross-sectional an.pdfPublished ...
Qiu YY +9 more
europepmc +2 more sources
Anti-Cyclic Citrullinated Peptide Antibody as a Predictor of Rheumathoid Arthritis Complications. [PDF]
Med Arch, 2020 Rheumatoid arthritis (RA) is a chronic systemic autoimmune disease, with more frequent occurrence in the female gender, it primarily affects the lining of the synovial joints, and is associated with lower quality of life, inability to work, progressive disability, and all of these patients are more likely to develop other comorbidities.To display the ...
Mekic M, Hadzigrahic E.
europepmc +4 more sources
Anti-cyclic citrullinated peptide antibody (ACPA) and Rheumatoid arthritis: Clinical relevance. [PDF]
J Clin Orthop Trauma, 2022 Rheumatoid Arthritis (RA) is the most common auto-immune, chronic inflammatory joint disease. Predominantly a musculoskeletal condition with a wide spectrum of skeletal and extra-skeletal manifestations, RA has a significant footfall in orthopaedic clinical practice worldwide. RA is essentially a clinical diagnosis; however, laboratory and radiographic
Iyengar KP, Vaish A, Nune A.
europepmc +4 more sources
The prevalence of anti-cyclic citrullinated peptide antibodies in juvenile idiopathic arthritis [PDF]
Jornal de Pediatria, 2005 OBJETIVOS: Avaliar a presença de anticorpos contra peptídeos cíclicos citrulinados em uma coorte de pacientes com artrite idiopática juvenil. MÉTODOS: A presença de anticorpos contra peptídeos cíclicos citrulinados foi avaliada por ensaio imunoenzimático
Machado, Sandra H. +8 more
core +5 more sources
Human host defence peptide LL37 and anti-cyclic citrullinated peptide antibody in early inflammatory arthritis [PDF]
RMD Open, 2019 Objective Antibodies to citrullinated peptides (anti-CCP) develop in individuals predisposed to rheumatoid arthritis (RA). Neutrophil extracellular traps are a major source of citrullinated antigens and the immunomodulatory host defence peptide LL-37 ...
Carol A Hitchon +3 more
doaj +2 more sources
Anti-Cyclic Citrullinated Peptide Antibody and Periodontal Status in Rheumatoid Arthritis Patients. [PDF]
Pak J Med Sci, 2018 Objectives: Studies have shown that periodontal disease and Rheumatoid Arthritis (RA) shared similar pathogenesis. Anti-Cyclic Citrullinated Peptide anibodies (anti-CCP) has recently been used for diagnosis of RA. Thus, this study aimed to assess the levels of anti-CCP antibodies and periodontal status in RA patients.Methods: Forty four RA patients ...
Mohamad WMW +3 more
europepmc +3 more sources
Development of synthetic anti-cyclic citrullinated peptide antibody and its arthritogenic role. [PDF]
Clin Transl Immunology, 2015 This study was undertaken to develop a novel anti‐citrullinated peptide antibody (ACPA) and to investigate its arthritogenicity in a collagen‐induced arthritis (CIA) model. The novel ACPA, 12G1, was developed by injecting cyclic citrullinated antigen in mice and subsequently hybridizing the B cells producing citrullinated peptide‐specific antibodies ...
Kim Y +6 more
europepmc +5 more sources